Skip to main content

Table 2 Assessment of administration of included studies

From: Thoracic perfusion of recombinant human endostatin (Endostar) combined with chemotherapeutic agents versus chemotherapeutic agents alone for treating malignant pleural effusions: a systematic evaluation and meta-analysis

Study

Trial group (N)

Control group (N)

Interventions

Treatment cycle

Termination of treatment

Endostar combined with chemotherapeutic agents

Chemotherapeutic agents alone

Liu W 2010 [15]

32

32

Cisplatin 40 mg/m2, 1/week

Endostar 30 mg, 1/week

Cisplatin 40 mg/m2, 1/w

3 weeks

>3 weeks, or pleural effusion disappeared

Mao L 2011 [16]

45

45

Cisplatin 40 mg/m2, 1/week

Endostar 30 mg, 2/week

Cisplatin 40 mg/m2, 1/7d

7d/cycle,

2 cycles

>4 cycles, or pleural effusion disappeared

Li G 2011 [17]

30

30

Bleomycin 60 mg, 1/week

Endostar 30 mg, 1/week

Bleomycin 60 mg, 1/w

3 weeks

>3 weeks, or pleural effusion disappeared

Ma E 2012 [18]

28

28

Cisplatin 40 mg/m2, 1/week

Endostar 30 mg, 1/week

Cisplatin 40 mg/m2, 1/w

4 weeks

>4 weeks, or pleural effusion disappeared

Yao Q 2012 [19]

30

30

Nedaplatin 40 mg, 1/week

Endostar 45 mg, 1/week

Nedaplatin 40 mg, 1/w

4 weeks

>4 weeks, or pleural effusion disappeared

Zheng Q 2013 [20]

60

60

Cisplatin 30–40 mg, d1–3

Endostar 90 mg, d4

Cisplatin 30–40 mg d1–3

21d/cycle,

1–4 cycles

>4 cycles, or pleural effusion disappeared

Kang Y 2013 [21]

45

45

Cisplatin 40 mg, 2/week

Endostar 30 mg, 2/week

Cisplatin 40 mg, 2/w

3 weeks

>3 weeks, or pleural effusion disappeared

Wen J 2014 [22]

25

29

Lobaplatin 30 mg/m2, d1

Endostar 30 mg, d1

Lobaplatin 30 mg/m2, d1

4 cycles

>4 cycles, or pleural effusion disappeared

Yue G 2014 [23]

43

43

Cisplatin 60 mg, 1/week

Endostar 30 mg, 2/week

Cisplatin 60 mg, 1/w

2–3 weeks

>4 weeks, or pleural effusion disappeared

Tu J [24]

45

45

Cisplatin 40 mg/m2, 2/week

Endostar 45 mg, 2/week

Cisplatin 40 mg/m2, 2/w

3 weeks

>3 weeks, or pleural effusion disappeared

Xu J 2014 [25]

35

35

Nedaplatin 60 mg, 1/week

Endostar 60 mg, 1/week

Nedaplatin 60 mg, 1/w

4 weeks

>4 weeks, or pleural effusion disappeared

Wen X 2015 [26]

68

36

Bleomycin 45 mg, w1

Endostar 45 mg, w2

Bleomycin 45 mg, 1/7d

7d/cycle,

2–4 cycles

>2 weeks, or pleural effusion disappeared

Hu X 2015 [27]

43

41

Cisplatin 40 mg, 2/week

Endostar 60 mg, 2/week

Cisplatin 40 mg, 2/week

2 weeks

>2 weeks, or pleural effusion disappeared

  1. N numbers of patients, d day, w week